Kaneka Corporation

Tatsumasa Mae

Mikio Kitahara

Kaku Nakagawa

Misuzu Tsukagawa

Minpei Kuroda

Yoshihiro Mimaki

Yutaka Sashida

Yasuyoshi Ueda

Shiro Kitamura

Takayoshi Hidaka

Jun Tomono

Hideyuki Kishida

Hiromi Maeda

Kazuya Hamada

Shinichi Yokota

Mitsuaki Kitano

Hiroaki Inoue

Yui Kawashima

Souichi Morikawa

Yoshitomo Sakamoto

Provided is a liquid food composition capable of semi-solidifying in the stomach, which is a one-pack type product containing a water-soluble dietary fiber preliminarily added thereto and in the form of a liquid that can be easily taken, and stably sustains the liquid nature thereof during distribution and storage. The liquid food composition, which is capable of semi-solidifying in an acidic region, comprises a water-soluble dietary fiber (a), a specific metal compound (b), a protein (c) and an emulsifier (d), and the particle size distribution of particles contained in said liquid food composition shows two or more peaks in a neutral region.

Treatment method using liquid food composition

Liquid food composition

A composition for preventing or ameliorating multiple risk factor syndrome involving visceral fat-type obesity, diabetes mellitus, hyperlipemia and hypertension, which comprises at least one member selected from the group consisting of a licorice hydrophobic extract, a turmeric extract, a clove extract, and a cinnamon extract.

Compositions for preventing or ameliorating multiple risk factor syndromes

The present invention easily and efficiently provides a peroxisome proliferator-activated receptor ligand, and a composition for amelioration of insulin resistance or for prevention and/or amelioration of the insulin resistance syndrome containing the same, as an active ingredient. The present invention relates to a peroxisome proliferator-activated receptor ligand which comprises a prenylflavonoid, a chalcone derivative exclusive of prenylflavonoids, a flavonol derivative exclusive of prenylflavonoids, and a salt, a glycoside and/or an esterified substance thereof acceptable as a pharmaceutical preparation or a food or a beverage; a composition containing the above ligand; a plant-derived extract containing the above ligand; and a process for producing the above extract.

Peroxisome proliferator activated receptor ligand and process for producing the same

The object of the present invention is to provide PPAR&#x3b3; ligand derived from naturally occurring sources and a composition for preventing and/or improving Insulin Resistance Syndrome, diabetes mellitus, obesity or visceral fat obesity comprising the PPAR&#x3b3; ligand as an active agent. The present invention relates to a ligand for peroxisome proliferator-activated receptor The composition according to the present invention, which comprises the PPAR&#x3b3; ligand as an active agent is useful for preventing and/or improving Insulin Resistance Syndrome, diabetes mellitus, obesity or visceral fat obesity.

Ligand for peroxisome proliferator-activated receptor

The present invention has for its object to provide a medicinal composition comprising coenzyme Q,as an active ingredient, which composition features an enhanced absorption after oral administration. The present invention is directed to a medicinal composition comprising coenzyme Q,as an active ingredient with the reduced form of coenzyme Q,accounting for more than 20 weight % of said coenzyme Q,.

Pharmaceutical composition comprising coenzyme Q10

The present invention has its object to provide an antihypercholesterolemic or antihyperlipidemic agent, hence a therapeutic and prophylactic drug for arteriosclerosis, which is safer and more potent in cholesterol-lowering action than the hitherto-available drugs. A cholesterol-lowering composition comprising a coenzyme Q of the following formula (I) or a reduced coenzyme Q of the following formula (II) as an active ingredient: ##STR1## wherein n represents an integer of 6 to 11

Cholesterol-lowering composition

Growing community of inventors

Kakogawa, Japan

Tatsumasa Mae